液体医療用酸素市場：モダリティ、治療用途、エンドユーザー別-2025～2030年の世界予測

液体医療用酸素市場は、2023年に89億9,000万米ドルと評価され、2024年には95億2,000万米ドルに達すると予測され、CAGR 9.26％で成長し、2030年には167億2,000万米ドルになると予測されています。

液体医療用酸素（LMO）は医療における重要なコンポーネントであり、主に呼吸療法、手術、集中治療室で使用され、重篤なケースでも患者の生存を保証します。その需要はCOVID-19の大流行時に急増し、呼吸器系の問題やその他の医療緊急事態を管理する際の必要性が浮き彫りになりました。LMOの中心的な用途は酸素療法にあり、慢性閉塞性肺疾患（COPD）、低酸素症、さまざまな心肺障害などの症状を助ける。この高い需要が、病院、クリニック、救急医療センター、在宅医療での最終用途を後押ししています。LMO市場は、人口の高齢化、呼吸器疾患の有病率の増加、在宅医療ソリューションに対する需要の高まりによって牽引されています。さらに、効果的な貯蔵・流通システムなどの技術的進歩と政府の医療構想が相まって、市場の成長ポテンシャルを高めています。しかし、市場は厳しい規制の枠組み、地方における物流の課題、生産・貯蔵インフラの高コストといった課題に直面しています。純度レベルの向上、蒸発ロスを減らすための容器技術の改善、生産における環境に優しいエネルギー源の採用など、機会は豊富にあります。最先端技術への投資によって高い運用コストを相殺することで、新たな市場の道をさらに開くことができます。小型のポータブル酸素システムとスマート酸素供給装置における革新は、拡大への未開拓の可能性を示しています。優位に立つためには、利害関係者は生産効率の最適化と輸送コストの削減に関する調査に注力すべきです。成長のもう一つの道は、直接供給契約のための病院との提携と、需要を合理化し患者の転帰を改善できる遠隔医療の進歩にあります。さらに、サステイナブル調達と生産を模索することで、環境への懸念に対処することができるため、環境意識の高まりの中でビジネスを有利に位置づけることができます。LMO市場は、公衆衛生の動向と施策に本質的に依存しており、規制の変化と医療需要への継続的な適応が求められています。

市場力学：急速に進化する液体医療用酸素市場の主要市場洞察を公開

液体医療用酸素市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性呼吸器疾患の高い蔓延
  • 各国における高齢化人口の増加
  • 医療産業における高純度酸素源の選好
• 市場抑制要因
  • 液体医療用酸素の入手可能性と供給の制限
• 市場機会
  • 医療施設への投資と施設数の増加
  • ポータブル液体酸素デバイスの利用拡大
• 市場課題
  • 液体医療用酸素の特殊な保管・取り扱い要件

ポーターのファイブフォース：液体医療用酸素市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、液体医療用酸素市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：液体医療用酸素市場における外部からの影響の把握

外部マクロ環境要因は、液体医療用酸素市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：液体医療用酸素市場における競合情勢の把握

液体医療用酸素市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：液体医療用酸素市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、液体医療用酸素市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：液体医療用酸素市場における成功への道筋を描く

液体医療用酸素市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性呼吸器疾患の有病率が高い
    • 各国で高齢化が進む
    • 医療産業からの高純度酸素源の優先
  • 抑制要因
    • 液体医療用酸素の在庫と供給が限られている
  • 機会
    • 医療施設への投資と数の増加
    • 携帯型液体酸素装置の新たな利用
  • 課題
    • 液体医療用酸素の特定の保管と取り扱い要件
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 液体医療用酸素市場：モダリティ別

• イントロダクション
• ポータブル酸素システム
• 据置型/独立型酸素システム

第7章 液体医療用酸素市場：治療用途別

• イントロダクション
• 一酸化炭素中毒
• 心臓発作
• 高熱
• 肺と心臓の病気
• 交通事故
• 重度の失血

第8章 液体医療用酸素市場：エンドユーザー別

• イントロダクション
• 外来手術センター
• 救急医療センター
• 在宅医療
• 病院

第9章 南北アメリカの液体医療用酸素市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋の液体医療用酸素市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの液体医療用酸素市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Air Products and Chemicals, Inc.
• Airgas, Inc.
• Atlas Copco
• GCE Group AB
• INOX-Air Products Inc.
• Les Gaz Industriels Ltd.
• Linde PLC
• Matheson Tri-Gas, Inc.
• Messer Group GmbH
• National Gases Limited
• Organa International
• Purity Cylinder Gases, Inc.
• SOL Group
• TAIYO NIPPON SANSO CORPORATION

LIST OF FIGURES

• FIGURE 1. LIQUID MEDICAL OXYGEN MARKET RESEARCH PROCESS
• FIGURE 2. LIQUID MEDICAL OXYGEN MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL LIQUID MEDICAL OXYGEN MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL LIQUID MEDICAL OXYGEN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL LIQUID MEDICAL OXYGEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS LIQUID MEDICAL OXYGEN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS LIQUID MEDICAL OXYGEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES LIQUID MEDICAL OXYGEN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES LIQUID MEDICAL OXYGEN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC LIQUID MEDICAL OXYGEN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC LIQUID MEDICAL OXYGEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA LIQUID MEDICAL OXYGEN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LIQUID MEDICAL OXYGEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. LIQUID MEDICAL OXYGEN MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. LIQUID MEDICAL OXYGEN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. LIQUID MEDICAL OXYGEN MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL LIQUID MEDICAL OXYGEN MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL LIQUID MEDICAL OXYGEN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL LIQUID MEDICAL OXYGEN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. LIQUID MEDICAL OXYGEN MARKET DYNAMICS
• TABLE 7. GLOBAL LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL LIQUID MEDICAL OXYGEN MARKET SIZE, BY PORTABLE OXYGEN SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL LIQUID MEDICAL OXYGEN MARKET SIZE, BY STATIONARY/STANDALONE OXYGEN SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL LIQUID MEDICAL OXYGEN MARKET SIZE, BY CARBON MONOXIDE POISONING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL LIQUID MEDICAL OXYGEN MARKET SIZE, BY HEART ATTACKS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL LIQUID MEDICAL OXYGEN MARKET SIZE, BY HIGH FEVERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL LIQUID MEDICAL OXYGEN MARKET SIZE, BY LUNG & HEART CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL LIQUID MEDICAL OXYGEN MARKET SIZE, BY ROAD TRAFFIC ACCIDENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL LIQUID MEDICAL OXYGEN MARKET SIZE, BY SEVERE BLOOD LOSS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL LIQUID MEDICAL OXYGEN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL LIQUID MEDICAL OXYGEN MARKET SIZE, BY EMERGENCY MEDICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL LIQUID MEDICAL OXYGEN MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL LIQUID MEDICAL OXYGEN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS LIQUID MEDICAL OXYGEN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 32. CANADA LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 33. CANADA LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. CANADA LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES LIQUID MEDICAL OXYGEN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC LIQUID MEDICAL OXYGEN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. CHINA LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 50. CHINA LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. CHINA LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. INDIA LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 53. INDIA LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. INDIA LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA LIQUID MEDICAL OXYGEN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 104. ITALY LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 105. ITALY LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. ITALY LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 116. POLAND LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 117. POLAND LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. POLAND LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 119. QATAR LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 120. QATAR LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. QATAR LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM LIQUID MEDICAL OXYGEN MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM LIQUID MEDICAL OXYGEN MARKET SIZE, BY TREATMENT APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM LIQUID MEDICAL OXYGEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 149. LIQUID MEDICAL OXYGEN MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 150. LIQUID MEDICAL OXYGEN MARKET, FPNV POSITIONING MATRIX, 2023

The Liquid Medical Oxygen Market was valued at USD 8.99 billion in 2023, expected to reach USD 9.52 billion in 2024, and is projected to grow at a CAGR of 9.26%, to USD 16.72 billion by 2030.

Liquid medical oxygen (LMO) is a critical component in healthcare, primarily used in respiratory therapy, surgeries, and intensive care units, ensuring patient survival in critical cases. Its demand surged during the COVID-19 pandemic, highlighting its necessity when managing respiratory issues and other medical emergencies. LMO's core application lies in oxygen therapy, aiding conditions like chronic obstructive pulmonary disease (COPD), hypoxia, and various cardiopulmonary disorders. This high demand pushes its end-use in hospitals, clinics, emergency medical centers, and home healthcare settings. The LMO market is driven by an aging population, increasing prevalence of respiratory ailments, and the escalating demand for home healthcare solutions. Furthermore, technological advancements like effective storage and distribution systems, coupled with government healthcare initiatives, amplify the market's growth potential. However, the market faces challenges like stringent regulatory frameworks, logistical challenges in rural areas, and the high cost of production and storage infrastructure. Opportunities abound in enhancing purity levels, improving container technology to reduce evaporation loss, and employing eco-friendly energy sources in production. Offsetting the high operational costs by investing in cutting-edge technologies can further open new market avenues. Innovations in smaller, portable oxygen systems and smart oxygen delivery devices present untapped potential for expansion. To excel, stakeholders should focus on research in optimizing production efficiency and reducing transportation costs. Another avenue for growth lies in partnerships with hospitals for direct supply contracts and advancements in telemedicine, which can streamline demand and deliver better patient outcomes. Moreover, exploring sustainable sourcing and production can address environmental concerns, thus positioning businesses favorably amid growing ecological awareness. The LMO market remains intrinsically dependent on public health trends and policies, demanding continuous adaptation to regulatory changes and healthcare demands.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Liquid Medical Oxygen Market

The Liquid Medical Oxygen Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • High prevalence of chronic respiratory diseases
  • Increasing aging population across countries
  • Preference for high purity oxygen sources from medical industry
• Market Restraints
  • Limited availability and supply of liquid medical oxygen
• Market Opportunities
  • Increasing investment and the number of healthcare facilities
  • Emerging use of portable liquid oxygen devices
• Market Challenges
  • Specific storage and handling requirements of liquid medical oxygen

Porter's Five Forces: A Strategic Tool for Navigating the Liquid Medical Oxygen Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Liquid Medical Oxygen Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Liquid Medical Oxygen Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Liquid Medical Oxygen Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Liquid Medical Oxygen Market

A detailed market share analysis in the Liquid Medical Oxygen Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Liquid Medical Oxygen Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Liquid Medical Oxygen Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Liquid Medical Oxygen Market

A strategic analysis of the Liquid Medical Oxygen Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Liquid Medical Oxygen Market, highlighting leading vendors and their innovative profiles. These include Air Products and Chemicals, Inc., Airgas, Inc., Atlas Copco, GCE Group AB, INOX-Air Products Inc., Les Gaz Industriels Ltd., Linde PLC, Matheson Tri-Gas, Inc., Messer Group GmbH, National Gases Limited, Organa International, Purity Cylinder Gases, Inc., SOL Group, and TAIYO NIPPON SANSO CORPORATION.

Market Segmentation & Coverage

This research report categorizes the Liquid Medical Oxygen Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Modality, market is studied across Portable Oxygen System and Stationary/Standalone Oxygen System.
• Based on Treatment Application, market is studied across Carbon Monoxide Poisoning, Heart Attacks, High Fevers, Lung & Heart Conditions, Road Traffic Accident, and Severe Blood Loss.
• Based on End User, market is studied across Ambulatory Surgical Centers, Emergency Medical Centers, Home Care Settings, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. High prevalence of chronic respiratory diseases
    • 5.1.1.2. Increasing aging population across countries
    • 5.1.1.3. Preference for high purity oxygen sources from medical industry
  • 5.1.2. Restraints
    • 5.1.2.1. Limited availability and supply of liquid medical oxygen
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing investment and the number of healthcare facilities
    • 5.1.3.2. Emerging use of portable liquid oxygen devices
  • 5.1.4. Challenges
    • 5.1.4.1. Specific storage and handling requirements of liquid medical oxygen
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Liquid Medical Oxygen Market, by Modality

• 6.1. Introduction
• 6.2. Portable Oxygen System
• 6.3. Stationary/Standalone Oxygen System

7. Liquid Medical Oxygen Market, by Treatment Application

• 7.1. Introduction
• 7.2. Carbon Monoxide Poisoning
• 7.3. Heart Attacks
• 7.4. High Fevers
• 7.5. Lung & Heart Conditions
• 7.6. Road Traffic Accident
• 7.7. Severe Blood Loss

8. Liquid Medical Oxygen Market, by End User

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Emergency Medical Centers
• 8.4. Home Care Settings
• 8.5. Hospitals

9. Americas Liquid Medical Oxygen Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Liquid Medical Oxygen Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Liquid Medical Oxygen Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Air Products and Chemicals, Inc.
• 2. Airgas, Inc.
• 3. Atlas Copco
• 4. GCE Group AB
• 5. INOX-Air Products Inc.
• 6. Les Gaz Industriels Ltd.
• 7. Linde PLC
• 8. Matheson Tri-Gas, Inc.
• 9. Messer Group GmbH
• 10. National Gases Limited
• 11. Organa International
• 12. Purity Cylinder Gases, Inc.
• 13. SOL Group
• 14. TAIYO NIPPON SANSO CORPORATION